研究兴趣

论文共 50 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity and Overcomes Resistance in KRAS-Mutant Tumors and BCR-ABL-Positive Leukemia
Ziwei Luo, Chencen Lin, Chuwei Yu, Changxian Yuan, Wenyong Wu, Xiaowei Xu, Renhong Sun, Yan Jia, Yafang Wang,Jie Shen, Dingyan Wang, Sinan Wang,Hualiang Jiang, Biao Jiang, Xiaobao Yang,Chengying Xie
Cancer research (2024)
引用0浏览0WOS引用
0
0
Discovery of Novel BCL6-Targeting PROTACs with Effective Antitumor Activities Against DLBCL in Vitro and in Vivo
Dazhao Mi, Cheng Li,Yuzhan Li,Mingyue Yao, Yan Li, Keyu Hong,Chengying Xie,Yihua Chen
European Journal of Medicinal Chemistry (2024): 116789-116789
引用0浏览0WOS引用
0
0
Unraveling the CDK9/PP2A/ERK Network in Transcriptional Pause Release and Complement Activation in KRAS-mutant Cancers
Yafang Wang,Lansong Xu, Lijun Ling,Mingyue Yao, Shangxuan Shi,Chengcheng Yu, Yingnian Li,Jie Shen,Hualiang Jiang,Chengying Xie
Advanced science (Weinheim, Baden-Wurttemberg, Germany)no. 41 (2024): e2404926-e2404926
引用0浏览0WOS引用
0
0
Targeting ST8SIA6-AS1 Counteracts KRASG12C Inhibitor Resistance Through Abolishing the Reciprocal Activation of PLK1/c-Myc Signaling
Yafang Wang, Mingyue Yao,Cheng Li, Kexin Yang, Xiaolong Qin, Lansong Xu, Shangxuan Shi, Chengcheng Yu, Xiangjun Meng,Chengying Xie
Experimental Hematology &amp Oncologyno. 1 (2023)
引用0浏览0引用
0
0
加载更多
作者统计

#Papers: 49

#Citation: 1483

H-Index: 18

G-Index: 38

Sociability: 5

Diversity: 3

Activity: 12

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn